Latest News
 

FDA approves first retinal implant for adults with rare genetic eye disease

The U.S. Food and Drug Administration has approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter mounted on a pair of eyeglasses, video processing unit (VPU) and an implanted retinal prosthesis (artificial retina), replaces the function of degenerated cells in the retina (a membrane inside the eye) and may improve a patient's ability to perceive images and movement. The VPU transforms images from the video camera into electronic data that is wirelessly transmitted to the retinal prosthesis.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Consumers largely underestimating calorie content of fast food

  • Students perform well regardless of reading print or digital books

  • Driving and hands-free talking lead to spike in errors

  • MRI-based measurement helps predict vascular disease in the brain

  • Future doctors unaware of their obesity bias

  • New insights contradict promising Alzheimer's research

  • Immune cell activation in multiple sclerosis: New indicator molecules visualize activation of auto-aggressive T cells

  • Help at hand for schizophrenics

  • Cause of infantile amnesia revealed: New neuron formation could increase capacity for new learning, at expense of old memories

  • Hormone levels may provide key to understanding psychological disorders in women

  •  
     
     

     

     

     

    Sign up
    Receive our
    free newsletter.
    View past issues

     
    Very interesting.
    I especially liked the jungle test in the fun tests.
    - Dan Bierenga
    All fun and informative tests,
    I shared them with all my friends. Great way to better understand folks.
    - Matthew McAvoy

     

     

    Personality Test Center
    © 2012


    IPIP NEO™ | Power tests | Type theory | Fun tests
    Polls |
    Privacy Policy | Contact | Home